Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Elpis Biopharmaceuticals logo — New Treatments. New Hope.

Elpis Biopharmaceuticals

New Treatments. New Hope.

Founded 2017 United States Lexington, United States 11 employees Biotechnology

General Information

Company Name Elpis Biopharmaceuticals
Founded Year 2017
Location United States Lexington, United States +1
Employees 11
Industries Biotechnology
Social

Get notified when Elpis Biopharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Elpis Biopharmaceuticals

Elpis Biopharmaceuticals is a biotechnology startup committed to developing next-generation cellular and biologic therapeutics for the treatment of cancer patients. Since its establishment in 2017, the company has been dedicated to providing new hope through their slogan "New Treatments. New Hope." As of now, Elpis Biopharmaceuticals does not have publicly available information regarding their headquarters, last investment, or the investors involved. As the biopharmaceutical industry continues to be a critical area of focus for the healthcare sector, the innovative approach and commitment of Elpis Biopharmaceuticals position them as an intriguing prospect for potential investors seeking to support advancements in cancer treatment.

Taxonomy: Biopharmaceuticals, Cellular Therapeutics, Biologic Therapeutics, Cancer Treatment, Immuno-Therapy, Immuno-Oncology, Antibody Discovery, CAR-T Discovery, Next Generation Therapeutics

No funding data available for Elpis Biopharmaceuticals yet.

Get notified when Elpis Biopharmaceuticals raises funding

Elpis Biopharmaceuticals Alternatives & Competitors

Elpis Biopharmaceuticals vs
Sitryx
Sitryx United Kingdom

Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therapies

Series A
48 employees
Biotechnology, Health Care
Elpis Biopharmaceuticals vs
Hinge Therapeutics
Hinge Therapeutics United States

Hinge Therapeutics is an early-stage biopharmaceutical company which focuses on developing therapies...

4 employees
Biotechnology, Health Care
Elpis Biopharmaceuticals vs
Microbiotica
Microbiotica United Kingdom

The microbiome is a new approach to medicine, offering potential for significant advancements. Micro...

Series Unknown
49 employees
Biotechnology, Health Care

FAQ About Elpis Biopharmaceuticals

New Treatments. New Hope.
Elpis Biopharmaceuticals was founded in 2017.
Elpis Biopharmaceuticals is headquartered in Lexington, United States.
Elpis Biopharmaceuticals operates in the following industries: Biotechnology.
Elpis Biopharmaceuticals has approximately 11 employees.
Top alternatives and competitors to Elpis Biopharmaceuticals include Sitryx, Hinge Therapeutics, Microbiotica , Cairn Biosciences, Kanaph Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Elpis Biopharmaceuticals and Sitryx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Elpis Biopharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes